Englisch

Eligibility Type 2 Diabetes NCT00451620

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
type 2 diabetes > 3 months duration
Beschreibung

Non-Insulin-Dependent Diabetes Mellitus disease length

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0011860
UMLS CUI [1,2]
C0872146
male or female
Beschreibung

Gender

Datentyp

boolean

Alias
UMLS CUI [1]
C0079399
over 65 years of age
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
diet controlled only
Beschreibung

Dietary control

Datentyp

boolean

Alias
UMLS CUI [1]
C0743195
hgba1c < 8.5%
Beschreibung

Glucohemoglobin measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C0202054
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
treatment with oral hypoglycemic agents or insulin or the likelihood of requiring treatment with these during the study.
Beschreibung

Oral hypoglycemic | Insulin regime

Datentyp

boolean

Alias
UMLS CUI [1]
C0359086
UMLS CUI [2]
C0557978
anemia - hgb below 130 g/l (males) and below 120 g/l (females).
Beschreibung

Anemia | Hemoglobin measurement | Gender

Datentyp

boolean

Alias
UMLS CUI [1]
C0002871
UMLS CUI [2]
C0518015
UMLS CUI [3]
C0079399
taking medications that known to interfere with glucose metabolism eg systemic corticosteriods, non-selective beta blockers.
Beschreibung

Pharmaceutical Preparations Interfere with glucose metabolism | CORTICOSTEROIDS FOR SYSTEMIC USE | Non-selective beta-blocking agent

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0521102
UMLS CUI [1,3]
C0596620
UMLS CUI [2]
C3653708
UMLS CUI [3]
C0304515
known or suspected allergy to glyburide, sulfa drugs or gluconorm impaired liver function, as shown by but not limited to ast and/or alt > 2x the upper limit of normal.
Beschreibung

Hypersensitivity Glyburide | Allergy to sulfonamides | Hypersensitivity NovoNorm | Liver Dysfunction | Aspartate aminotransferase increased | Alanine aminotransferase increased

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0017628
UMLS CUI [2]
C0038757
UMLS CUI [3,1]
C0020517
UMLS CUI [3,2]
C0732644
UMLS CUI [4]
C0086565
UMLS CUI [5]
C0151904
UMLS CUI [6]
C0151905
impaired renal function, as shown by but not limited to serum creatinine > 133 µmol/l (males) or 124 µmol/l (females).
Beschreibung

Renal Insufficiency | Creatinine measurement, serum | Gender

Datentyp

boolean

Alias
UMLS CUI [1]
C1565489
UMLS CUI [2]
C0201976
UMLS CUI [3]
C0079399
participated in another clinical trial within the past 30 days.
Beschreibung

Study Subject Participation Status

Datentyp

boolean

Alias
UMLS CUI [1]
C2348568
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Type 2 Diabetes NCT00451620

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Non-Insulin-Dependent Diabetes Mellitus disease length
Item
type 2 diabetes > 3 months duration
boolean
C0011860 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
Gender
Item
male or female
boolean
C0079399 (UMLS CUI [1])
Age
Item
over 65 years of age
boolean
C0001779 (UMLS CUI [1])
Dietary control
Item
diet controlled only
boolean
C0743195 (UMLS CUI [1])
Glucohemoglobin measurement
Item
hgba1c < 8.5%
boolean
C0202054 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Oral hypoglycemic | Insulin regime
Item
treatment with oral hypoglycemic agents or insulin or the likelihood of requiring treatment with these during the study.
boolean
C0359086 (UMLS CUI [1])
C0557978 (UMLS CUI [2])
Anemia | Hemoglobin measurement | Gender
Item
anemia - hgb below 130 g/l (males) and below 120 g/l (females).
boolean
C0002871 (UMLS CUI [1])
C0518015 (UMLS CUI [2])
C0079399 (UMLS CUI [3])
Pharmaceutical Preparations Interfere with glucose metabolism | CORTICOSTEROIDS FOR SYSTEMIC USE | Non-selective beta-blocking agent
Item
taking medications that known to interfere with glucose metabolism eg systemic corticosteriods, non-selective beta blockers.
boolean
C0013227 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C0596620 (UMLS CUI [1,3])
C3653708 (UMLS CUI [2])
C0304515 (UMLS CUI [3])
Hypersensitivity Glyburide | Allergy to sulfonamides | Hypersensitivity NovoNorm | Liver Dysfunction | Aspartate aminotransferase increased | Alanine aminotransferase increased
Item
known or suspected allergy to glyburide, sulfa drugs or gluconorm impaired liver function, as shown by but not limited to ast and/or alt > 2x the upper limit of normal.
boolean
C0020517 (UMLS CUI [1,1])
C0017628 (UMLS CUI [1,2])
C0038757 (UMLS CUI [2])
C0020517 (UMLS CUI [3,1])
C0732644 (UMLS CUI [3,2])
C0086565 (UMLS CUI [4])
C0151904 (UMLS CUI [5])
C0151905 (UMLS CUI [6])
Renal Insufficiency | Creatinine measurement, serum | Gender
Item
impaired renal function, as shown by but not limited to serum creatinine > 133 µmol/l (males) or 124 µmol/l (females).
boolean
C1565489 (UMLS CUI [1])
C0201976 (UMLS CUI [2])
C0079399 (UMLS CUI [3])
Study Subject Participation Status
Item
participated in another clinical trial within the past 30 days.
boolean
C2348568 (UMLS CUI [1])
Zum Seitenanfang zurückkehren